OPPENHEIMER ASSET MANAGEMENT INC. - PUMA BIOTECHNOLOGY INC ownership

PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 129 filers reported holding PUMA BIOTECHNOLOGY INC in Q2 2020. The put-call ratio across all filers is 2.10 and the average weighting 0.0%.

Quarter-by-quarter ownership
OPPENHEIMER ASSET MANAGEMENT INC. ownership history of PUMA BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2021$209,000
-19.0%
29,815
+6.1%
0.00%
-25.0%
Q2 2021$258,000
-31.2%
28,105
-27.1%
0.00%
-33.3%
Q1 2021$375,000
-3.1%
38,549
+2.1%
0.01%0.0%
Q4 2020$387,000
+4.0%
37,748
+2.4%
0.01%
-14.3%
Q3 2020$372,000
+38.3%
36,851
+43.0%
0.01%
+16.7%
Q2 2020$269,000
+86.8%
25,769
+51.4%
0.01%
+50.0%
Q1 2020$144,000
+65.5%
17,015
+71.8%
0.00%
+100.0%
Q4 2019$87,000
-14.7%
9,905
+4.0%
0.00%0.0%
Q3 2019$102,000
+18.6%
9,521
+40.3%
0.00%0.0%
Q2 2019$86,000
-65.7%
6,784
+4.7%
0.00%
-66.7%
Q1 2019$251,000
+146.1%
6,477
+28.9%
0.01%
+100.0%
Q4 2018$102,000
-52.1%
5,023
+7.9%
0.00%
-40.0%
Q3 2018$213,000
+634.5%
4,656
+1832.0%
0.01%
+400.0%
Q3 2017$29,000
+20.8%
241
-11.7%
0.00%0.0%
Q2 2017$24,000
+50.0%
273
-35.5%
0.00%
Q1 2017$16,0004230.00%
Other shareholders
PUMA BIOTECHNOLOGY INC shareholders Q2 2020
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 1,300,000$13,338,0002.17%
Camber Capital Management LP 2,555,000$26,214,0000.92%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,959,741$40,627,0000.80%
Palo Alto Investors LP 1,373,897$14,096,0000.74%
Sofinnova Investments, Inc. 629,650$6,460,0000.38%
RICE HALL JAMES & ASSOCIATES, LLC 604,937$6,207,0000.22%
J. Goldman & Co LP 238,617$2,448,0000.12%
GLOBEFLEX CAPITAL L P 55,027$565,0000.12%
FRED ALGER MANAGEMENT, LLC 3,416,003$35,048,0000.09%
JUPITER ASSET MANAGEMENT LTD 728,440$7,474,0000.08%
View complete list of PUMA BIOTECHNOLOGY INC shareholders